Use of Progestogen Tied to Higher Chance of Benign Brain Tumor

Many people worldwide use progestogen-based hormonal contraception or hormone replacement therapy to manage menopause symptoms. Previous research has linked a handful of high-dose progestogens—cyproterone acetate, nomegestrol acetate, and chlormadinone acetate—with increased risk of meningiomas, a common type of brain tumor that is generally noncancerous.